Saccaro coming back to Baxter as spin-off plans gain pace
This article was originally published in Clinica
Executive Summary
James Saccaro will re-join Baxter International as chief financial officer, filling the vacancy left by current CFO Robert Hombach when he moves to the firm’s spun-out biopharmaceuticals company. The spin-out is due to complete in mid-2015. Mr Saccaro, who will report to current Baxter CEO and chair Robert Parkinson, joined the firm in 2002, reaching the position of elected corporate vice-president and treasurer in 2011. However, most recently Mr Saccaro was senior vice-president and CFO at healthcare solutions firm Hill-Rom.